Claudia Ottka

This study examines how obesity and sarcopenia alter metabolite profiles in dogs, finding increased inflammation and lipid metabolism disruptions in overweight dogs and modest metabolic effects in those with reduced muscle mass.

The paper identifies metabolic changes in dogs with elevated blood creatinine using NMR metabolomics, finding associations with several biomarkers and suggesting potential diagnostic and therapeutic targets.

This paper develops and validates a quantitative NMR-based metabolomics platform for canine serum and plasma, defining reference intervals and demonstrating its clinical relevance.